132 related articles for article (PubMed ID: 35454831)
1. Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer.
Lubbers JM; Ważyńska MA; van Rooij N; Kol A; Workel HH; Plat A; Paijens ST; Vlaming MR; Spierings DCJ; Elsinga PH; Bremer E; Nijman HW; de Bruyn M
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454831
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer.
Workel HH; van Rooij N; Plat A; Spierings DCJ; Fehrmann RSN; Nijman HW; de Bruyn M
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471032
[TBL] [Abstract][Full Text] [Related]
3. Immune profiling identifies CD8
Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
Front Immunol; 2022; 13():894919. PubMed ID: 36420264
[TBL] [Abstract][Full Text] [Related]
4. CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden.
van den Bulk J; van der Ploeg M; Ijsselsteijn ME; Ruano D; van der Breggen R; Duhen R; Peeters KCMJ; Fariña-Sarasqueta A; Verdegaal EME; van der Burg SH; Duhen T; de Miranda NFCC
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36792124
[TBL] [Abstract][Full Text] [Related]
5. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.
Laumont CM; Wouters MCA; Smazynski J; Gierc NS; Chavez EA; Chong LC; Thornton S; Milne K; Webb JR; Steidl C; Nelson BH
Clin Cancer Res; 2021 Jul; 27(14):4089-4100. PubMed ID: 33963000
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.
Duhen T; Duhen R; Montler R; Moses J; Moudgil T; de Miranda NF; Goodall CP; Blair TC; Fox BA; McDermott JE; Chang SC; Grunkemeier G; Leidner R; Bell RB; Weinberg AD
Nat Commun; 2018 Jul; 9(1):2724. PubMed ID: 30006565
[TBL] [Abstract][Full Text] [Related]
7. CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39.
Zhang X; Ouyang X; Xu Z; Chen J; Huang Q; Liu Y; Xu T; Wang J; Olsen N; Xu A; Zheng SG
Mol Ther; 2019 Nov; 27(11):1963-1973. PubMed ID: 31402273
[TBL] [Abstract][Full Text] [Related]
8. CD103
Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
[TBL] [Abstract][Full Text] [Related]
9. Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer.
Gorchs L; Fernández-Moro C; Asplund E; Oosthoek M; Solders M; Ghorbani P; Sparrelid E; Rangelova E; Löhr MJ; Kaipe H
Cancer Res Commun; 2024 Feb; 4(2):460-474. PubMed ID: 38335302
[TBL] [Abstract][Full Text] [Related]
10. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
[TBL] [Abstract][Full Text] [Related]
11. CD39 Identifies the CD4
Kortekaas KE; Santegoets SJ; Sturm G; Ehsan I; van Egmond SL; Finotello F; Trajanoski Z; Welters MJP; van Poelgeest MIE; van der Burg SH
Cancer Immunol Res; 2020 Oct; 8(10):1311-1321. PubMed ID: 32759363
[TBL] [Abstract][Full Text] [Related]
12. Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8+ T cells in Breast Cancer Implications for Adoptive Cell Therapy.
Gattas GI; Noël G; López F; González F; Prieto-Hinojosa A; Nava-Rivera LE; Willard-Gallo K; Argüello JR
Curr Pharm Biotechnol; 2023 Sep; ():. PubMed ID: 37680154
[TBL] [Abstract][Full Text] [Related]
13. Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy.
Shen YC; Yeh CP; Jeng YM; Hsu C; Hsu CH; Lin ZZ; Shao YY; Lu LC; Liu TH; Chen CH; Cheng AL
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680292
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma.
Dong DN; Fan PW; Feng YN; Liu GH; Peng YC; Dong T; Wang RZ; Yu JM
Chin Med J (Engl); 2021 Aug; 134(17):2066-2072. PubMed ID: 34435978
[TBL] [Abstract][Full Text] [Related]
15. Implication of CD69
Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
[TBL] [Abstract][Full Text] [Related]
16. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
17. 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39
Leem G; Park J; Jeon M; Kim ES; Kim SW; Lee YJ; Choi SJ; Choi B; Park S; Ju YS; Jung I; Kim S; Shin EC; Lee JY; Park SH
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335029
[TBL] [Abstract][Full Text] [Related]
18. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
[TBL] [Abstract][Full Text] [Related]
19. CD103
Wang P; Huang B; Gao Y; Yang J; Liang Z; Zhang N; Fu X; Li L
Cell Immunol; 2018 Mar; 325():48-55. PubMed ID: 29448979
[TBL] [Abstract][Full Text] [Related]
20. CD39
Shen Y; Qiu Y; Duan ZQ; Li YX; Wang Y; Zhang YY; Zhu BH; Yu XH; Tan XL; Chen W; Zhuang Y; Zou QM; Ma DY; Peng LS
Pharmacol Res; 2024 Apr; 202():107122. PubMed ID: 38428703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
